Logo Logo Logo Logo Logo
RTSL News

Rapid Therapeutic Selects Clinical Research Center to Start Clinical Trials Using its Proprietary CBD and CBG Formulation

December 3, 2020
RTSL News

Rapid Therapeutic Completes $14 Million Acquisition of Razor Jacket

December 1, 2020
RTSL News

Rapid Therapeutic Enters Letter of Intent to Expand Production Capability to 3,000,000 MDI and $100,000,000 in Revenue Annually

September 30, 2020
RTSL News

Rapid Therapeutic Announces Completion of New ISO 13485 Laboratory

August 18, 2020
RTSL News

Rapid Therapeutic Science Laboratories (RTSL), Inc. engages Ezzey Digital Marketing Agency to Launch its New Lifestyle Brand “nhāler”

August 6, 2020
RTSL News

Rapid Therapeutic Science Files with FDA to Register Facility and Products

August 4, 2020
RTSL News

Rapid Therapeutic Completes Delivery of Additional 6,000 Units of its Proprietary Metered Dose Inhalers

July 14, 2020
RTSL News

Rapid Therapeutic Announces Major Contract is Increased by 150% to 250,000 Metered Dose Inhalers

July 9, 2020
RTSL News

Rapid Therapeutic Completes Initial Delivery of 2,000 Units of its Proprietary Metered Dose Inhalers

July 8, 2020
RTSL News

Rapid Therapeutic Enters Contract for Certified Lab for Manufacturing Consistent with FDA Rules

June 30, 2020
  • 1
  • 2
Hottest Stuff Now
Sorry, no posts matched your criteria.
FOLLOW US #QODETHEMES
QodeThemes
It seams that you haven't connected with your Twitter account
INSTAGRAM FEED
Sign Up & Get FREE News Alerts From FNM Today!
Sign Up

Terms of Service | Privacy Policy | Disclaimer

FinancialNewsMedia.com (FNM) is a third party publisher and news dissemination solutions provider of multimedia platforms that enable officers & directors, corporate communicators, public relations and investor relations officers to leverage content to engage with all their key audiences. Any ideas and opinions presented in any FNM News Alerts, Video clips, Press Releases, RSS Feeds or Social Network Posts are for informational purposes only, and do not reflect the opinions of FNM or any of its affiliates, subsidiaries or partners. UNDER NO CIRCUMSTANCES SHOULD ANY CONTENT CONTAINED HEREIN BE INTERPRETED TO REPRESENT TRADING OR INVESTMENT ADVICE. All viewers agree that under no circumstances will FNM, its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information contained on this or any affiliated website.
© 2020 Financial News Media. All Rights Reserved.